| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $0 | — |
| SG&A Expense | $65K | +156.9% |
| Operating Income | -$65K | -156.9% |
| Interest Expense | $11K | +0.0% |
| Net Income | -$76K | -110.9% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Total Assets | $100K | +70.2% |
| Current Liabilities | $672K | +21.0% |
| Total Liabilities | $672K | +21.0% |
| Stockholders' Equity | -$572K | -15.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59K | -184.0% |
| Financing Cash Flow | $100K | +33.3% |